Breaking News

Yapan Bio Adds New Process Development Facility

Expands capacity and capabilities in large molecule therapeutics to support development and manufacturing of RNA, DNA and gene therapy products.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Piramal Pharma Limited (PPL) announced that Yapan Bio has expanded its capabilities with a new process development facility at Genome Valley, Hyderabad, India.   PPL holds a strategic minority stake in Yapan and markets its services through Piramal Pharma Solutions (PPS), a Contract Development and Manufacturing Organization (CDMO) serving the global pharma and biopharma market.   With this expansion, Yapan has enhanced its ability to support end-to-end development and manufacturing of RNA, ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters